Vaccine certification for travel must meet 'minimum criteria': UK

London: The UK government has said that COVID-19 vaccine certification from all countries must meet a minimum criteria and that it is working with India on a phased approach to its international travel norms.

It follows Covishield, the Serum Institute of India manufactured Oxford/AstraZeneca vaccine, being added as eligible to an expanded UK travel advisory on Wednesday.

But with India's vaccine certification not on a list of 18 approved countries, Indian travellers to the UK will continue to be treated as non-vaccinated and therefore required to quarantine for 10 days on arrival.

Following much confusion over this process, UK government sources said on Wednesday night that additions or changes to the approved country listings are being kept under regular consideration, but there was no further clarity on the required criteria for approving a country's vaccine certification. As part of our recently expanded inbound vaccination policy, we recognise the following vaccines Pfizer BioNTech, Oxford AstraZeneca, Moderna and Janssen (J&J), for the purposes of international travel. This now includes the formulations AstraZeneca Covishield, AstraZeneca Vaxzevria and Moderna Takeda, a UK government spokesperson said.

Our top priority remains protecting public health, and reopening travel in a safe and sustainable way, which is why vaccine certification from all countries must meet the minimum criteria taking into account public health and wider considerations, the spokesperson said.